Superficial Vein Thrombosis Management: John Fanikos Shares Latest Review
John Fanikos, Director of Strategic Initiatives at North American Thrombosis Forum, shared a post on LinkedIn:
“Once again the hard work of the Thrombosis Research Group is making the news.
Superficial Vein Thrombosis (in contrast to deep vein thrombosis) has represented a treatment challenge for clinicians. In this review, blood clot size (> 5 centimeters) and location (<3 centimeters from a deep vein) matters.
This directs the treatment choice of anticoagulation (fondaparinux, rivaroxaban) versus conservative management (warm compresses, ibuprofen, compression stockings).
Kudos to the clinicians, Drs. Piazza, Krishnathasan, Hamade, Ujueta, Scimeca, Goldhaber, Bikdeli et al. Thank you for including me.
You can visit the Vasculearn Network and find stories from patients on the Discussion Board about their diagnosis and treatment journey.”
Title: Superficial Vein Thrombosis
Authors: Gregory Piazza, Darsiya Krishnathasan, Nada Hamade, Francisco Ujueta, Giovanni Scimeca, Marcos D. Ortiz-Rios, Bridget McGonagle, Jean-Philippe Galanaud, David Jiménez, Manuel Monreal, John Fanikos, Anahita Dua, Leben Tefera, Raghu Kolluri, Sahil A. Parikh, Walter Ageno, Samuel Z. Goldhaber, Jeffrey I. Weitz, Lisa K. Moores, Isabelle Quéré, Behnood Bikdeli
Read the full article here.
Stay updated on the latest news in the field of thrombosis with Hemostasis Today.
-
Dec 18, 2025, 23:14The “Normal” FVIII Level Trap in Females with Haemophilia
-
Dec 18, 2025, 23:11WFH Expands Multidisciplinary Bleeding Disorder Training in Vietnam
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
-
Dec 18, 2025, 15:12Wolfgang Miesbach on Insights from Guy Young’s ASH2025 Session on Next-Generation Gene Therapy
-
Dec 18, 2025, 14:15Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List